Breadcrumb Inicio Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 125 studies. P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded P1031A: International Mother-Infant Rapid Intervention At Delivery DAIDS Number 10042 Research Area Other Study Status Concluded P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up P1025: Perinatal Core Protocol DAIDS Number 10039 Research Area Prevention Study Status Concluded P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded P1021: FTC + EFV + ddI Didanosine QD in Naive Children DAIDS Number 10038 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded Pagination Previous page Prev Página 1 … Página 5 Página 6 Página 7 Página 8 Página 9 Página 10 Current page 11 Página 12 Página 13 Next page Next
P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded
P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded
P1031A: International Mother-Infant Rapid Intervention At Delivery DAIDS Number 10042 Research Area Other Study Status Concluded
P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded
P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up
P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded
P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded
P1021: FTC + EFV + ddI Didanosine QD in Naive Children DAIDS Number 10038 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
